Home/Filings/4/0001209191-14-047440
4//SEC Filing

MEI Pharma, Inc. 4

Accession 0001209191-14-047440

$LITSCIK 0001262104operating

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 4:16 PM ET

Size

5.8 KB

Accession

0001209191-14-047440

Insider Transaction Report

Form 4
Period: 2014-07-14
Zech Thomas M.
Chief Financial Officer
Transactions
  • Award

    Option to purchase shares of common stock

    2014-07-14+30,000151,000 total
    Exercise: $6.53Exp: 2019-07-14Common Stock par value $0.00000002 (30,000 underlying)
Footnotes (2)
  • [F1]One-quarter of the options will vest on July 14, 2015; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.
  • [F2]The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001262104

Filing Metadata

Form type
4
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:16 PM ET
Size
5.8 KB